Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1

Status

Completed 4Terminated 3Unknown 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × thymoglobulin × Clear all
NCT00679536 2014-01-23

Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1/2 Unknown
30 enrolled
Other hematologic neoplasm

Graft vs Host Disease, Leukemia

NCT00887042 2012-03-26

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

The Korean Society of Pediatric Hematology Oncology

Phase 1/2 Unknown
35 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡